Therapeutic choices in the current millennium: hemophilia workshop highlights.
Many issues affect hemophilia care providers when managing bleeding episodes in individuals with hemophilia. A diverse group of hemophilia providers from the United States met at two workshops to discuss the issues influencing treatment choices in the current millennium and to learn about current advances in treatment of hemophilia. This paper provides a summary of the discussions at these workshops. Despite the progress made in the management of patients with hemophilia, the workshop highlighted the fact that there were still many unanswered questions.
Mathew
Prasad
P
Department of Pediatrics, University of New Mexico, Albuquerque, NM 87131, USA. pmathew@salud.unm.edu
Manno
Catherine S
CS
Aledort
Louis M
LM
D005169:Factor VIII / Q000627:therapeutic use; D006467:Hemophilia A / Q000097:blood / Q000628:therapy*; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use
D011994:Recombinant Proteins; D005169:Factor VIII